INTRODUCTION: Tuberculosis is difficult to diagnose and it is the leading cause of death in HIV infected individuals in developing countries. There is an urgent need of low-cost diagnostic markers for resource-limited settings. METHODS: The study involved 1571 patients from an HIV cohort study in India with known serum albumin concentrations at the time of becoming eligible for antiretroviral therapy (ART). We investigated the diagnostic accuracy of serum albumin to predict tuberculosis within six months of ART eligibility and the prognostic value in patients who experienced tuberculosis. RESULTS: The diagnostic accuracy of serum albumin, measured by the area under the receiver operating characteristic curve, to predict tuberculosis was 0.81 (95% confidence interval 0.78-0.83). Serum albumin concentrations <3.2 g/dL were associated with 85% specificity and <4.1 g/dL were associated with negative predictive values >90%, even in settings with high tuberculosis prevalence. Hypoalbuminemia was associated with an increased risk of mortality in patients with tuberculosis. CONCLUSION: Serum albumin can be a useful low-cost diagnostic marker for tuberculosis in HIV infected patients eligible for ART. However, we failed to find thresholds to rule out or rule in tuberculosis. If these results are confirmed by other studies, serum albumin could be used to improve the diagnostic accuracy of intensive case finding algorithms for HIV-related tuberculosis. In patients who experience tuberculosis, hypoalbuminemia is associated with poor prognosis.
INTRODUCTION:Tuberculosis is difficult to diagnose and it is the leading cause of death in HIV infected individuals in developing countries. There is an urgent need of low-cost diagnostic markers for resource-limited settings. METHODS: The study involved 1571 patients from an HIV cohort study in India with known serum albumin concentrations at the time of becoming eligible for antiretroviral therapy (ART). We investigated the diagnostic accuracy of serum albumin to predict tuberculosis within six months of ART eligibility and the prognostic value in patients who experienced tuberculosis. RESULTS: The diagnostic accuracy of serum albumin, measured by the area under the receiver operating characteristic curve, to predict tuberculosis was 0.81 (95% confidence interval 0.78-0.83). Serum albumin concentrations <3.2 g/dL were associated with 85% specificity and <4.1 g/dL were associated with negative predictive values >90%, even in settings with high tuberculosis prevalence. Hypoalbuminemia was associated with an increased risk of mortality in patients with tuberculosis. CONCLUSION:Serum albumin can be a useful low-cost diagnostic marker for tuberculosis in HIV infectedpatients eligible for ART. However, we failed to find thresholds to rule out or rule in tuberculosis. If these results are confirmed by other studies, serum albumin could be used to improve the diagnostic accuracy of intensive case finding algorithms for HIV-related tuberculosis. In patients who experience tuberculosis, hypoalbuminemia is associated with poor prognosis.
Entities:
Keywords:
Cost Savings; Developing Countries; Hypoalbuminemia; India; Mortality; Public Health
Authors: Stephen D Lawn; Anthony D Harries; Graeme Meintjes; Haileyesus Getahun; Diane V Havlir; Robin Wood Journal: AIDS Date: 2012-11-13 Impact factor: 4.177
Authors: P Tabarsi; E Chitsaz; A Moradi; P Baghaei; P Farnia; M Marjani; M Shamai; M Amiri; S Nikaein; D Mansouri; M Masjedi; F Altice Journal: Int J STD AIDS Date: 2012-09 Impact factor: 1.359
Authors: Serena P Koenig; Cynthia Riviere; Paul Leger; Patrice Joseph; Patrice Severe; Kea Parker; Sean Collins; Erin Lee; Jean W Pape; Daniel W Fitzgerald Journal: Clin Infect Dis Date: 2009-03-15 Impact factor: 9.079
Authors: Molebogeng X Rangaka; Robert J Wilkinson; Judith R Glynn; Andrew Boulle; Gilles van Cutsem; Rene Goliath; Shaheed Mathee; Gary Maartens Journal: Clin Infect Dis Date: 2012-09-05 Impact factor: 9.079
Authors: Ako A Agbor; Jean Joel R Bigna; Serges Clotaire Billong; Mathurin Cyrille Tejiokem; Gabriel L Ekali; Claudia S Plottel; Jean Jacques N Noubiap; Hortence Abessolo; Roselyne Toby; Sinata Koulla-Shiro Journal: PLoS One Date: 2014-12-15 Impact factor: 3.240
Authors: Kuteesa R Bisaso; Joel S Owen; Francis W Ojara; Proscovia M Namuwenge; Apollo Mugisha; Lawrence Mbuagbaw; Livingstone S Luboobi; Jackson K Mukonzo Journal: In Silico Pharmacol Date: 2014-09-16